Evidence map›Paper›PMID 41315482›Full record

ArticleScientific reports2025

Computed tomography-based nnU-Net for region-specific brain structural changes across the alzheimer's continuum and frontotemporal dementia subtypes.

Seongbeom Park, Kyoungmin Kim, Kyoung Yoon Lim, Duk L Na, Hee Jin Kim, Hyemin Jang, Jun Pyo Kim, Sung Hoon Kang, Jihwan Yun, Min Young Chun and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Seongbeom Park *BeauBrain Healthcare, Inc., Seoul, South Korea.
Kyoungmin Kim *Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, South Korea.
Kyoung Yoon LimBeauBrain Healthcare, Inc., Seoul, South Korea.
Duk L NaAlzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, South Korea.
Hee Jin KimAlzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, South Korea.
Hyemin JangDepartment of Neurology, Asan Medical Center, Seoul, South Korea.
Jun Pyo KimAlzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, South Korea.
Sung Hoon KangDepartment of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, South Korea.
Jihwan YunDepartment of Neurology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, South Korea.
Min Young ChunDepartment of Neurology, Yonsei University College of Medicine, Seoul, South Korea.
Sang Won Seo *Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, South Korea. sangwonseo@empas.com.
Kichang Kwak *BeauBrain Healthcare, Inc., Seoul, South Korea. kichang.kwak@beaubrain.bio.

Funding

Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea HU20C0111National Research Foundation of Korea NRF-2019R1A5A2027340Research of Korea Disease Control and Prevention Agency 2021-ER1006-00
6 · The paper itself

Abstract

Quantifying structural brain changes is critical for diagnosing and monitoring neurodegenerative diseases. Although magnetic resonance imaging (MRI) is the silver standard, limited accessibility and cost hamper routine use. We developed a deep learning-based framework using the nnU-Net for brain segmentation using computed tomography (CT) to assess cerebrospinal fluid (CSF) volume changes, as an indirect marker of tissue loss, and evaluated its utility across Alzheimer's disease (AD) stages and frontotemporal dementia (FTD) subtypes. We included 2357 participants: cognitively unimpaired (CU, n = 595), mild cognitive impairment (MCI, n = 954), dementia of Alzheimer's type (DAT, n = 663), and FTD subtypes (FTD, n = 145, behavioral variant FTD (bvFTD, n = 66), nonfluent variant primary progressive aphasia (nfvPPA, n = 29), and semantic variant PPA (svPPA, n = 50). CT-based segmentation was trained and validated using 3D T1-weighted MRI as reference. We assessed (1) segmentation accuracy via Dice similarity coefficients (DSCs), (2) reliability and precision using correlation and Bland-Altman analyses, and (3) clinical utility by identifying stage- and region-specific changes in CSF volumes. Key regions, including anterior and posterior lateral ventricles, showed DSCs above 0.93 and correlations ranging from 0.822 to 0.996. CT-based measurements revealed increasing CSF volumes from CU to DAT and distinct patterns of CSF volume enlargement across FTD subtypes. This framework enables accurate, reliable assessment of CSF volume changes as an indirect marker of atrophy, and supports early detection and differential diagnosis.

Indexed as

Alzheimer DiseaseBrainFrontotemporal DementiaTomography, X-Ray ComputedAgedAged, 80 and overCognitive DysfunctionDeep LearningFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedAlzheimer disease frontotemporal dementia computed tomographyBrain segmentationDeep learning

Identifiers

PMID41315482
PMCPMC12663231

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.